Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The pharmaceutical intermediates market is expected to grow at a CAGR of 7.2% between 2023 to 2032.

The rising demand to treat chronic diseases increases the requirements of pharmaceutical intermediates. Additionally the demand for APIs in the coming years will also rise due to surging prevalence of infectious diseases which in turn will bolster the growth of the global pharmaceutical intermediate market.

The pharmaceutical intermediates market size was estimated to be US$ 29.5 billion in 2021.

The raw materials that are used in the production of bulk drugs are known as pharmaceutical intermediates. They are produced during the synthesis of active pharmaceutical ingredient (API) as a byproduct.

Major players in the global pharmaceutical intermediates market are BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle, Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, Life Sciences Private Limited and others.